National Pharmaceutical Pricing Authority seeks drug stock, pricing data

The regulator had earlier asked the drug makers and groups to share details regarding the price movement, production details and inventory of active pharmaceutical ingredients (APIs) and key starting material (KSM) of 58 crucial APIs that are imported from China so as curb possible shortages of molecules.

Source: The Economic Times - March 12, 2020 Category: Consumer Health News Source Type: news